S&P Equity Research Downgrades Allergan (AGN) to Sell
Tweet Send to a Friend
S&P Equity Research downgrades Allergan (NYSE: AGN) from Hold to Sell.
S&P analyst, P. Seligman, says, "While AGN said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
S&P analyst, P. Seligman, says, "While AGN said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
